Boosting India's GDP: Pharma and MedTech Global Hub Vision
Dr. Jitendra Singh, Union Minister, envisioned a transformative role for India's pharma and MedTech sectors in propelling national GDP during his keynote at New Delhi's Healthcare Summit on Saturday....
Dr. Jitendra Singh, Union Minister, envisioned a transformative role for India's pharma and MedTech sectors in propelling national GDP during his keynote at New Delhi's Healthcare Summit on Saturday.
India's integrated ecosystem of pharmaceuticals, medical technology, and manufacturing is redefining global healthcare access through affordable, top-tier solutions. Discussions zeroed in on 'Made in India' and quality benchmarks, fostering innovation tied to international norms.
The past ten years mark a renaissance: import dependency for vital implants, drugs, and devices has plummeted, slashing costs and democratizing healthcare.
India now leads in developing antibiotics, vaccines, and advanced interventions. COVID-19 exemplified this—domestic vaccines not only saved lives at home but were exported globally, solidifying India's credible image.
Quality leaps are evident in indigenous stents, ventilators, and diagnostics, which meet rigorous global criteria while remaining economical and dependable.
The PRIP scheme, with Rs 5,000 crore funding, champions research to elevate India from cost-leader to innovation vanguard in these fields.
From a 1.5% global medical devices footprint, the National Medical Devices Policy 2023 sets ambitious goals for market dominance, promising substantial economic dividends.